Research ArticleBONE DISEASE

Sclerostin Inhibition Reverses Skeletal Fragility in an Lrp5-Deficient Mouse Model of OPPG Syndrome

See allHide authors and affiliations

Science Translational Medicine  13 Nov 2013:
Vol. 5, Issue 211, pp. 211ra158
DOI: 10.1126/scitranslmed.3006627

Log in to view Figures & Data

Log in through your institution

Log in through your institution

Stay Connected to Science Translational Medicine